European Respiratory Society, 2021
Neuropilin-2, the Specific Binding Partner to ATYR1923, Is Expressed in Sarcoid Granulomas and Key Immune Cells
American Thoracic Society, 2020
ATYR1923 Specifically Binds to Neuropilin-2, a Novel Therapeutic Target for the Treatment of Immune-Mediated Diseases
American Thoracic Society, 2020
ATYR1923 Modulates the Inflammatory Response in Experimental Models of Interstitial Lung Disease
American Thoracic Society, 2019
ATYR1923 Reduces Neutrophil Infiltration in an Acute Lipopolysaccharide (LPS) Lung Injury Model
Keystone Symposia, 2019
ATYR1923 Ameliorates Dermal and Pulmonary Fibrosis in a Murine Model of Sclerodermatous Chronic Graft vs. Host Disease
Scleroderma Foundation National Patient Education Conference, 2018
Preclinical Characterization of ATYR1923 (iMod.Fc), an Immune-Modulatory Therapeutic With Potentially Broad Application in Interstitial Lung Diseases
American Thoracic Society, 2018
Identification of a T Cell Immunomodulatory Domain in Histidyl-tRNA Synthetase
American Association of Immunologists, 2018
Resokine Modulates Immune Cell Infiltration Into the Lung and Provides Therapeutic Activity in a Bleomycin-induced Lung Fibrosis Model
American Thoracic Society, 2017
The Resokine Pathway is Implicated in the Pathology of Interstitial Lung Disease
American Thoracic Society, 2017